Borthwick, Alan D <br/><br/>
Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Jul 2002 
 - 1719-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0960-894X 
<br/><br/><label>Standard No.: </label>10.1016/s0960-894x(02)00294-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--chemistry<br/>Cytomegalovirus--enzymology<br/>Dansyl Compounds--chemistry<br/>Drug Stability<br/>Half-Life<br/>Humans<br/>Inhibitory Concentration 50<br/>Lactams--blood<br/>Proline--analogs & derivatives<br/>Protease Inhibitors--blood<br/>Pyrrolidines--blood<br/>Spectrometry, Mass, Electrospray Ionization